The BeyeOMARKER study design paper is out! In BeyeOMARKER we will screen 700 individuals with plasma p-tau217 at an eye clinic, and further characterize 150 of them with Amyloid & Tau PET, MRI, retinal imaging and cognitive & cortical vision assessment. Thanks to the great team at @AlzheimerAms, especially @ilse_bader, @j_milongo & @Colin__Groot. Link to paper @AlzheimersRes (open access) > pubmed.ncbi.nlm.nih.gov/3916…

Very pleased to introduce our newest team member Jean-Marie Milongo (@j_milongo), who will join the BeyeOMARKER study team as a research assistant. @AlzheimerAms @HealthHolland

The fact that this tweet has received (by far) the least impressions/engagements of all my #AAIC23 tweets shows how important it was to have this plenary. I learned a lot.